Company Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Equities
OJU1
US68403P2039
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.017 EUR | +0.50% |
|
-1.18% | -3.54% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14/13/14 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/07/23 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 09/22/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/07/23 |
Arie Mayer
BRD | Director/Board Member | 67 | 05/19/05 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,628,924 | 35,961,754 ( 88.51 %) | 0 | 88.51 % |
Company contact information
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.com![address Oramed Pharmaceuticals Inc.(OJU1)](https://cdn.zonebourse.com/static/address/12416907.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- ORMP Stock
- OJU1 Stock
- Company Oramed Pharmaceuticals Inc.